People in Print: Learn more about our physicians .

Derek Raghavan, M.D., Ph.D., F.A.C.P.
Chairman and Director
Cleveland Clinic Taussig Cancer Center

Dr. Raghaven joined the team at the Cleveland Clinic Taussig Cancer Center in March 2004, and rapidly set about the task of moving to a platform of multi-disciplinary translational research and treatment. Since March 2004, nearly a dozen new faculty have been recruited to the Cancer Center and arrangements have been made to establish new clinics, including a Clinical Psychology/Psychiatry/Behavioral Support Clinic, Geriatric Oncology Clinic, Bone Metastasis Clinic, and Consequences of Cure Clinic (studying late effects of treatment).

Dr. Raghavan originally trained in Australia and the United Kingdom, receiving his medical degree from the University of Sydney and a Ph.D. from the University of London, and then did post-doctoral studies at the University of Minnesota. After 10 years in Australia, he was recruited to Roswell Park Cancer Institute in 1991 to lead the Divisions of Solid Tumor Oncology and Investigational Therapeutics.

Dr. Raghavan moved to the University of Southern California (Los Angeles) in 1997 as associate director of the Norris Comprehensive Cancer Center and head of the Division of Oncology.

Dr. Raghavan is recognized for laboratory and clinical research in genitourinary cancer, with a focus on cancers of the bladder, testis and prostate. He has garnered extensive funding from national organizations, has published more than 200 papers and has edited several books.